Event Ophthalmic Drugs 2018
26 Nov 2018 - 27 Nov 2018
SMi Group are proud to present the 2nd Annual Ophthalmic Drugs Conference on 26th – 27th November 2018, London, United Kingdom.
As the global population ages, the incidence of ophthalmic disorders continues to grow, and thus the interest of pharmaceutical and biotech companies is increasingly focused towards innovation of novel approaches for the development of ophthalmic drugs, driving the growth of this market. In fact, the global ophthalmic drug market is projected to reach £30 billion by 2023, growing at a CAGR of 5.3% from 2017 to 2023 (Via *Allied Market Research)
Join industry experts from Roche, Santen, Aerie Pharmaceuticals, MHRA, Nightstar Therapeutics and more to discuss and analyze the latest advancements and challenges within ophthalmic drug development. Network with industry professionals, explore novel approaches to treatment of ocular diseases, gain insight into ongoing clinical trials, discover how technology is revolutionising pharmaceutical R&D, and get invaluable advice on how to enhance development and overcome challenges within the industry.
Visit the event website